Stay updated on Nivolumab & Ibrutinib in CNS Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab & Ibrutinib in CNS Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab & Ibrutinib in CNS Lymphoma Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The record now presents details for the completed phase II study of nivolumab and ibrutinib for relapsed or refractory central nervous system lymphoma, including study design, participant criteria, and outcome measures.
    Difference
    55%
    Check dated 2026-11-07T13:35:06.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The displayed ClinicalTrials.gov site revision changed from v3.7.2 to v3.8.0 while the page continued to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T14:33:49.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    A site-wide NIH banner announces updates and FAQs about the transition from “Artificial Intelligence” to “Super Intelligence” terminology.
    Difference
    1%
    Check dated 2026-10-24T13:49:04.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-17T13:54:15.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.0 to v3.7.1 while the page continued to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-10T13:52:30.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the study content and navigation with an error screen. This blocks access to the trial details, contacts, and locations that users normally rely on.
    Difference
    20%
    Check dated 2026-09-19T18:48:22.000Z thumbnail image

Stay in the know with updates to Nivolumab & Ibrutinib in CNS Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab & Ibrutinib in CNS Lymphoma Clinical Trial page.